Steroid-sensitive post-viral inflammatory pneumonitis (PVIP)

American Journal of Respiratory and Critical Care Medicine

Volumn 182, Issue 8, 2010, Pages 1089-1090

  Roberts, Catherine ^a   Nirmalan, Mahesh ^a   O'Shea, Sarah ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIVIRAL THERAPY; ARTIFICIAL VENTILATION; CASE REPORT; CLINICAL DECISION MAKING; CLINICAL PRACTICE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; EXUDATE; HUMAN; INFLUENZA VIRUS A H1N1; INTENSIVE CARE UNIT; LETTER; LUNG HEMORRHAGE; LUNG INFILTRATE; LYMPHOCYTIC INFILTRATION; MALE; OXYGENATION; PRIORITY JOURNAL; RESPIRATORY FAILURE; STEROID SENSITIVE POST VIRAL INFLAMMATORY PNEUMONITIS; TREATMENT DURATION; VIRUS PNEUMONIA; WEANING;

EID: 78049341515     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/ajrccm.182.8.1089a     Document Type: Letter

References (2)

1. Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, Tolley EA. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998;280:159-165.
2. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006;354:1671-1684.